The association between serum asymmetric dimethylarginine and coronary atherosclerotic plaque in an asymptomatic population

Chun Yao Huang, Jong Shiuan Yeh, Chun Ming Shih, Feng Yen Lin, Yung Ta Kao, Nai Wen Tsao, Wen Tien Hsiao, Jaw Wen Chen, Nen Chung Chang, Kou-Gi Shyu

Research output: Contribution to journalArticle

Abstract

Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide synthase and is independently associated with poor cardiovascular outcomes. However, the direct relationship between serum ADMA level and the extent of subclinical coronary atherosclerotic plaque has never been investigated. In total, 130 consecutive asymptomatic Taiwanese subjects (mean age, 55.6±10 years), who received a health screening evaluation, were enrolled. Coronary plaque detected by computed tomography coronary angiography (CTCA) was observed in 85 (65.4%) of 130 individuals. Patients with coronary plaque had a higher ADMA level (1.16±1.15 μmol/L vs. 0.42 ± 0.33 μmol /L, p

Original languageEnglish
Pages (from-to)236-243
Number of pages8
JournalImmunology, Endocrine and Metabolic Agents in Medicinal Chemistry
Volume12
Issue number3
Publication statusPublished - 2012

Fingerprint

Atherosclerotic Plaques
Serum
Population
Coronary Angiography
Nitric Oxide Synthase
Health
N,N-dimethylarginine

Keywords

  • Asymmetric dimethylarginine (ADMA)
  • Asymptomatic
  • Atherosclerotic plaque
  • Computed tomography coronary angiography (CTCA)
  • Coronary atherosclerosis
  • Endothelial dysfunction
  • Nitric oxide (NO)

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy
  • Pharmacology

Cite this

@article{db3396e18bfc4de5988efbd2b764dcad,
title = "The association between serum asymmetric dimethylarginine and coronary atherosclerotic plaque in an asymptomatic population",
abstract = "Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide synthase and is independently associated with poor cardiovascular outcomes. However, the direct relationship between serum ADMA level and the extent of subclinical coronary atherosclerotic plaque has never been investigated. In total, 130 consecutive asymptomatic Taiwanese subjects (mean age, 55.6±10 years), who received a health screening evaluation, were enrolled. Coronary plaque detected by computed tomography coronary angiography (CTCA) was observed in 85 (65.4{\%}) of 130 individuals. Patients with coronary plaque had a higher ADMA level (1.16±1.15 μmol/L vs. 0.42 ± 0.33 μmol /L, p",
keywords = "Asymmetric dimethylarginine (ADMA), Asymptomatic, Atherosclerotic plaque, Computed tomography coronary angiography (CTCA), Coronary atherosclerosis, Endothelial dysfunction, Nitric oxide (NO)",
author = "Huang, {Chun Yao} and Yeh, {Jong Shiuan} and Shih, {Chun Ming} and Lin, {Feng Yen} and Kao, {Yung Ta} and Tsao, {Nai Wen} and Hsiao, {Wen Tien} and Chen, {Jaw Wen} and Chang, {Nen Chung} and Kou-Gi Shyu",
year = "2012",
language = "English",
volume = "12",
pages = "236--243",
journal = "Anti-Infective Agents in Medicinal Chemistry",
issn = "2211-3525",
publisher = "Bentham Science Publishers",
number = "3",

}

TY - JOUR

T1 - The association between serum asymmetric dimethylarginine and coronary atherosclerotic plaque in an asymptomatic population

AU - Huang, Chun Yao

AU - Yeh, Jong Shiuan

AU - Shih, Chun Ming

AU - Lin, Feng Yen

AU - Kao, Yung Ta

AU - Tsao, Nai Wen

AU - Hsiao, Wen Tien

AU - Chen, Jaw Wen

AU - Chang, Nen Chung

AU - Shyu, Kou-Gi

PY - 2012

Y1 - 2012

N2 - Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide synthase and is independently associated with poor cardiovascular outcomes. However, the direct relationship between serum ADMA level and the extent of subclinical coronary atherosclerotic plaque has never been investigated. In total, 130 consecutive asymptomatic Taiwanese subjects (mean age, 55.6±10 years), who received a health screening evaluation, were enrolled. Coronary plaque detected by computed tomography coronary angiography (CTCA) was observed in 85 (65.4%) of 130 individuals. Patients with coronary plaque had a higher ADMA level (1.16±1.15 μmol/L vs. 0.42 ± 0.33 μmol /L, p

AB - Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide synthase and is independently associated with poor cardiovascular outcomes. However, the direct relationship between serum ADMA level and the extent of subclinical coronary atherosclerotic plaque has never been investigated. In total, 130 consecutive asymptomatic Taiwanese subjects (mean age, 55.6±10 years), who received a health screening evaluation, were enrolled. Coronary plaque detected by computed tomography coronary angiography (CTCA) was observed in 85 (65.4%) of 130 individuals. Patients with coronary plaque had a higher ADMA level (1.16±1.15 μmol/L vs. 0.42 ± 0.33 μmol /L, p

KW - Asymmetric dimethylarginine (ADMA)

KW - Asymptomatic

KW - Atherosclerotic plaque

KW - Computed tomography coronary angiography (CTCA)

KW - Coronary atherosclerosis

KW - Endothelial dysfunction

KW - Nitric oxide (NO)

UR - http://www.scopus.com/inward/record.url?scp=84866414086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866414086&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84866414086

VL - 12

SP - 236

EP - 243

JO - Anti-Infective Agents in Medicinal Chemistry

JF - Anti-Infective Agents in Medicinal Chemistry

SN - 2211-3525

IS - 3

ER -